Clinical trial
Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational…
NCT00087542 · ACADIA Pharmaceuticals Inc., Industry · Completed
Key facts
| NCT number | NCT00087542 |
|---|---|
| Title | Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug |
| Lead sponsor | ACADIA Pharmaceuticals Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hallucinations, Psychoses, Parkinson's Disease |
| Intervention type | Drug |
| Interventions | ACP-103 |
| Enrollment | 60 |
| Start date | Mar 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Jul 14, 2004 |
| Last update posted | Dec 7, 2005 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: